Is ICER NICEr?

Pharmacoeconomics. 2018 Apr;36(4):385-386. doi: 10.1007/s40273-018-0617-6.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cost-Benefit Analysis*
  • Drug Costs / trends*
  • Humans
  • Organizations / standards*